METHODS: All experiments were performed with measurement of continuous cystometry under urethane anesthesia. 1. Fiberphotometry: Optical probe was inserted into the ACC of Thy1-GCaMP (Green fluorescent protein-calmodulin protein) transgenic mice with a GCaMP in the brain cortex, and neural activity of the ACC was measured. 2. Optogenetics: To investigated excitatory neuron, photostimulation was performed with inserting an optical probe into the ACC of wild type mice and Thy1-ChR2 mice expressing ChR2 in cortex V layer excitatory neurons.
INTRODUCTION AND OBJECTIVES:
The bladder urothelium and detrusor layer express the succinate receptor, GPR91. The acute and immediate effects of its activation on bladder function have yet been described. The aim of this study is to demonstrate the acute effect of succinate activation of its receptor GPR91 on bladder contraction/ relaxation using a mouse model with specific deletion of the GPR91 receptor.
METHODS: Conscious cystometry was carried out on C57Bl6 and GPR91(-/-) mice with and without succinate intravesical instillation. Contractile properties of bladder strips from the 2 strains were analyzed by organ bath. Characteristics of bladder were analyzed by Masson's trichrome and immunoblotting. Primary urothelial cell culture from both groups were investigated for nitric oxide secretion (colorimetric assay), ATP and cGMP levels (commercial kits).
RESULTS: The body weight was similar between GPR91(-/-) and C57Bl6 mice, while the bladder mass was higher in GPR91(-/-) mice. Masson's trichrome revealed a thicker urothelium and lamina propria in GPR91(-/-) mice. Conscious cystometry showed that GPR91(-/-) mice had a lower bladder capacity, lower micturition volume and lower intercontraction interval. Intravesical instillation of succinate (10 mM) increased the bladder capacity in C57Bl6 mice only. In organ bath, bladder strips from C57Bl6 and GPR91(-/-) mice had similar contractions elicited by potassium chloride ,carbachol and electrical field stimulation. Succinate administration relaxed carbachol-stimulated strips in C57Bl6 mice only. In vitro, short-term secretion of nitric oxide by urothelial cells from C57Bl6 and KO mice were similar at all concentrations (from 200 µM to 10 mM), confirming that nitric oxide is not involved in relaxation elicited by succinate. Succinate did not affect cGMP levels either in cell culture but decreased ATP released into the culture medium.
CONCLUSIONS: These results suggest that succinate modulates the relaxation-contraction of the detrusor through its action on its receptor GPR91, possibly by decreasing ATP synthesis in the urothelium. Using the Water Avoidance Stress test (WAS), we tested the hypothesis that chronic stress increases NGF through the stimulation of A1A-AR. In addition, we investigated the effect of the blockade of the high affinity NGF receptor TrkA in bladder pain and bladder hyperactivity observed in this stress model. METHODS: Adult female Wistar rats were submitted to WAS, 1h/day for 10 days. Visceral pain behavioural tests were determined at day 0 and 10. At day 11, blood and urine were collected to analyse NGF levels by ELISA. After, rats were urethane anaesthetized and bladder reflex activity was determined by cystometry. WAS was repeated in rats orally treated with the TrkA antagonist GW441756, 58µg/kg/day, or the A1A-AR antagonist silodosin (0.2mg/kg/day). Sham rats were used as controls.
Bladder strips from intact animals were left in culture media with 1.25 g/l of phenylephrine for 24h to mimic the effect of stress on bladder tissue. Then, the medium was collected and NGF was measured. Appropriate control was used.
RESULTS: WAS increased plasmatic NGF levels from 32.17 AE18.32 pg/ml to 2088.47 AE 1027.16 pg/ml (p<0.001), urinary NGF levels in urine from 17.17 AE 1.73 pg/ml to 50.20 AE 25.37 pg/ml (p<0.001) and bladder reflex activity from 0.45 AE 0.05 to 0.83 AE 0.11 (p<0.001).
WAS increased pain behaviour score in Test A and Test B, from 0 AE 0 to 6 AE 5 (p < 0.05), and from 0 AE 0 to 8 AE 4 (p < 0.05), respectively. WAS lowered mechanical pain threshold from 40 AE 24 g to 6 AE 2 g (p<0.05).
Silodosin prevented plasmatic NGF increase (17.50 AE 0.53 pg/ ml). Adrenergic stimulation of bladder strips did not result in NGF release.
TrkA antagonist GW441756 blocked pain behaviour development (0AE0 to 0AE0, for test A and B) and prevented changes in mechanical pain threshold (37 AE 19 g to 25 AE 18 g; p[0.38) and on bladder reflex activity (0.6 AE 0.07, p<0.05 against WAS group).
CONCLUSIONS: Chronic stress induces visceral pain and bladder changes through an NGF-dependent sensitization of nociceptive fibres after A1A-AR. Hence plasmatic NGF may be used as diagnosis tool for chronic visceral painful conditions. Also, TrkA receptors antagonist/NGF sequestration, alone or in combination with A1A-AR antagonists may be seen as new therapeutic opportunities. 
MP62-11 SUPERNATANT FROM ACUTE UROPATHOGENIC E-COLI INFECTION EXCLUSIVELY SENSITISES HIGH THRESHOLD BLADDER AFFERENTS AND RECRUITS 'SILENT NOCICEPTORS'
Luke Grundy*, Adelaide, Australia; Glen Ulett, Gold Coast, Australia; Stuart Brierley, Adelaide, Australia INTRODUCTION AND OBJECTIVES: Uropathogenic E. coli (UPEC) is the primary cause of adult urinary tract infection (UTI) inducing the clinical symptoms of urgency, urinary frequency, and acute pelvic pain. Upon host invasion, UPEC infection initiates an innate inflammatory response characterised by chemokine secretion, the subsequent recruitment of immune cells, and the release of inflammatory cytokines. Despite this, the mechanisms underlying UPEC induced modulation of bladder afferent function have yet to be explored. The aim of this study was to investigate the role of soluble factors released during UTI on bladder afferent mechanosensitivity.
METHODS: Female C57BL/6 mice were inoculated using a transurethral method with either 10 9 colony-forming units of UPEC CFT073 (O6:H1:K2) in 40 mL of PBS, or PBS alone. At 24hrs post inoculation, mice were humanely killed and the bladder mucosa was isolated, homogenized, and centrifuged to elute a supernatant. Supernatants were pooled from multiple bladders and stored at -80 C before being diluted 1:10 with sterile saline and applied to the bladder lumen of separate female mice during graded bladder distension (0-50mmHg) with an ex-vivo bladder afferent nerve recording model. RESULTS: Bladder afferent mechanosensitivity (0-50mmHg) was significantly enhanced in the presence of supernatants from UPEC (p 0.001), but not PBS innoculated mice, in the absence of changes in muscle compliance. Notably, these effects were apparent at distension pressures above 25mmHg, indicating a predominant effect on nociceptive afferents. Analysis of single afferent activation thresholds identified subpopulations of low-and high-threshold mechanosensitive units. UPEC supernatants specifically sensitised high-threshold (p 0.001) but not low-threshold (p!0.05) mechanoreceptors to elicit enhanced responses to graded bladder distension. Furthermore, we identified a population of 'silent nociceptors', that become mechanoreceptors in the presence of UPEC but not PBS supernatants, further amplifying the neuronal sensitisation that occurs in the presence of the supernatant.
CONCLUSIONS: These data provide a novel mechanistic insight into how bladder infection with UPEC results in the symptoms of frequency, urgency, and pelvic pain. In addition, these data demonstrate a direct role for bladder afferents in mediating bladder hyperalgesia during UTI. 
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MP62-12 DYNAMIC ELASTICITY INDUCED VIA EXTERNAL COMPRESS-RELEASE PROTOCOL IN A PERFUSED PORCINE BLADDER MODEL
Andrea Balthazar*, Zachary Cullingsworth, Naveen Nandanan, Uzoma Anele, John Speich, Adam Klausner, Richmond, VA
INTRODUCTION AND OBJECTIVES:
In studies aimed at developing novel urodynamic (UD) metrics, our group previously identified the biomechanical properties strain softening (SS) and dynamic elasticity (DE) . During the UD protocol, repeat filling and passive bladder emptying resulted in a reduction of intravesical pressure, SS. Active voiding reverses SS restoring baseline pressure termed DE. Importantly DE shows, in contrast to previous beliefs, that bladder compliance can be acutely regulated. Because filling and passive emptying requires an invasive catheter, we hypothesized that bladder SS can be produced noninvasively using an external compress-release protocol. The aim was to determine if SS produced by filling and passive emptying is equivalent to SS produced by repeated external compressrelease in a porcine bladder model. METHODS: Ex vivo perfused porcine bladders were used for both passive emptying and external compress-release experiments. Passive emptying protocol, fig 1A: the bladder was filled to 250 ml (pre-SS pressure) and filling was continued to 500 ml (reference pressure). Then, the bladder was passively emptied via syringe aspiration to 250 ml (post-SS pressure). Next, the bladder was voided with high KCl buffer to induce "active" contraction and refilled back to 250 ml (post-void pressure) to demonstrate DE. Compress-release protocol, fig 1B: the bladder was filled to 250 ml, and external compression was applied to isovolumetrically increase intravesical pressure to the reference pressure. The compression was held for 15s and released for 15s for 5 cycles. Equilibrium pressure 5 min after release (post-SS) was noted. In both studies, the following pressures were compared: pre-SS, post-SS, post-void.
RESULTS: Ten bladders were studied. SS was demonstrated in both the passive emptying (p<0.05) and compress-release (p<0.05) protocols. The pressure after filling and passive emptying was not statistically different from the pressure after compression-release (p>0.05). The data suggests each method induced a similar degree of SS, fig 1C. CONCLUSIONS: Repeat external compression of the bladder can induce a similar degree of SS as compared to filling and passive emptying. This technique may represent a potential means to acutely regulate bladder compliance and be used as a therapy to treat urinary urgency.
